Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
about
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
P2860
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@ast
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@en
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@nl
type
label
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@ast
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@en
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@nl
prefLabel
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@ast
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@en
Anthracycline-free neoadjuvant ...... HER2+ breast cancer patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Anthracycline-free neoadjuvant ...... n HER2+ breast cancer patients
@en
P2093
Davide Lombardi
Debora Martorelli
Diana Crivellari
Elisa Comaro
Elisa Turchet
Renato Talamini
Simon Spazzapan
P2860
P2888
P356
10.1186/1471-2407-14-954
P407
P50
P577
2014-12-15T00:00:00Z
P5875
P6179
1040068788